vs
Side-by-side financial comparison of NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP (NEN) and Spero Therapeutics, Inc. (SPRO). Click either name above to swap in a different company.
NEW ENGLAND REALTY ASSOCIATES LIMITED PARTNERSHIP is the larger business by last-quarter revenue ($23.6M vs $12.6M, roughly 1.9× Spero Therapeutics, Inc.). Spero Therapeutics, Inc. runs the higher net margin — 250.7% vs -677.3%, a 928.0% gap on every dollar of revenue. On growth, Spero Therapeutics, Inc. posted the faster year-over-year revenue change (24080.8% vs 15.7%). Over the past eight quarters, Spero Therapeutics, Inc.'s revenue compounded faster (847.7% CAGR vs 8.9%).
New England Realty Associates Limited Partnership is a real estate investment entity that owns, operates and manages residential and commercial properties primarily across the U.S. New England region. Its core assets include multifamily apartments, mixed-use properties and small commercial spaces, serving tenants across Massachusetts, New Hampshire and adjacent states, delivering steady returns to unitholders via rental income and property value growth.
NEN vs SPRO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.6M | $12.6M |
| Net Profit | $-1.4M | $31.5M |
| Gross Margin | — | — |
| Operating Margin | 14.0% | — |
| Net Margin | -677.3% | 250.7% |
| Revenue YoY | 15.7% | 24080.8% |
| Net Profit YoY | -133.0% | 250.9% |
| EPS (diluted) | — | $0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.6M | $12.6M | ||
| Q3 25 | $23.7M | $0 | ||
| Q2 25 | $21.2M | $0 | ||
| Q1 25 | $20.7M | $12.0K | ||
| Q4 24 | $20.4M | $52.0K | ||
| Q3 24 | $20.2M | $65.0K | ||
| Q2 24 | $20.1M | $114.0K | ||
| Q1 24 | $19.9M | $140.0K |
| Q4 25 | $-1.4M | $31.5M | ||
| Q3 25 | $-521.8K | $-7.4M | ||
| Q2 25 | $4.1M | $-1.7M | ||
| Q1 25 | $3.8M | $-13.9M | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $3.9M | $-17.1M | ||
| Q2 24 | $4.1M | $-17.9M | ||
| Q1 24 | $3.5M | $-12.7M |
| Q4 25 | 14.0% | — | ||
| Q3 25 | 20.0% | — | ||
| Q2 25 | 33.3% | — | ||
| Q1 25 | 30.1% | -122758.3% | ||
| Q4 24 | 32.4% | — | ||
| Q3 24 | 32.0% | -28604.6% | ||
| Q2 24 | 32.6% | -16720.2% | ||
| Q1 24 | 28.9% | -9987.1% |
| Q4 25 | -677.3% | 250.7% | ||
| Q3 25 | -2.2% | — | ||
| Q2 25 | 19.5% | — | ||
| Q1 25 | 18.3% | -115550.0% | ||
| Q4 24 | 20.7% | — | ||
| Q3 24 | 19.3% | -26380.0% | ||
| Q2 24 | 20.3% | -15668.4% | ||
| Q1 24 | 17.4% | -9049.3% |
| Q4 25 | — | $0.56 | ||
| Q3 25 | — | $-0.13 | ||
| Q2 25 | — | $-0.03 | ||
| Q1 25 | — | $-0.25 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.32 | ||
| Q2 24 | — | $-0.33 | ||
| Q1 24 | — | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.7M | $40.3M |
| Total DebtLower is stronger | $531.0M | — |
| Stockholders' EquityBook value | — | $59.0M |
| Total Assets | $505.3M | $68.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.7M | $40.3M | ||
| Q3 25 | $13.4M | $48.6M | ||
| Q2 25 | $16.7M | $31.2M | ||
| Q1 25 | $30.9M | $48.9M | ||
| Q4 24 | $17.6M | $52.9M | ||
| Q3 24 | $15.1M | $76.3M | ||
| Q2 24 | $13.5M | $63.5M | ||
| Q1 24 | $28.8M | $82.3M |
| Q4 25 | $531.0M | — | ||
| Q3 25 | $514.2M | — | ||
| Q2 25 | $514.3M | — | ||
| Q1 25 | $407.8M | — | ||
| Q4 24 | $408.6M | — | ||
| Q3 24 | $409.3M | — | ||
| Q2 24 | $410.0M | — | ||
| Q1 24 | $410.7M | — |
| Q4 25 | — | $59.0M | ||
| Q3 25 | — | $26.5M | ||
| Q2 25 | — | $32.8M | ||
| Q1 25 | — | $33.8M | ||
| Q4 24 | — | $46.1M | ||
| Q3 24 | — | $65.5M | ||
| Q2 24 | — | $80.5M | ||
| Q1 24 | — | $96.2M |
| Q4 25 | $505.3M | $68.9M | ||
| Q3 25 | $492.9M | $54.2M | ||
| Q2 25 | $494.8M | $62.1M | ||
| Q1 25 | $385.2M | $77.7M | ||
| Q4 24 | $393.5M | $110.5M | ||
| Q3 24 | $387.4M | $135.2M | ||
| Q2 24 | $383.7M | $149.9M | ||
| Q1 24 | $381.2M | $167.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.7M | $-8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | -0.26× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.7M | $-8.4M | ||
| Q3 25 | $2.3M | $17.4M | ||
| Q2 25 | $12.5M | $-17.7M | ||
| Q1 25 | $5.5M | $-4.0M | ||
| Q4 24 | $31.9M | $-23.4M | ||
| Q3 24 | $8.5M | $12.8M | ||
| Q2 24 | $5.4M | $-18.7M | ||
| Q1 24 | $6.1M | $5.9M |
| Q4 25 | — | -0.26× | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.02× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 7.57× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | 1.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
